Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anxiety: An ignored aspect of Parkinson’s disease lacking attention
Dharmendra Kumar Khatri, Mamta Choudhary, Anika Sood, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110776-110776
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 60
Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
Dnyandev Gadhave, Vrashabh V. Sugandhi, Saurav Kumar Jha, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102357-102357
Open Access | Times Cited: 33
Unleashing creativity in people with Parkinson’s disease: a pilot study of a co-designed creative arts therapy
Blanca T. M. Spee, Nienke M. de Vries, Sara Zeggio, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access | Times Cited: 2
Effectiveness of Acupuncture for Anxiety Among Patients With Parkinson Disease
Jingqi Fan, Wei-Jing Lu, Weiqiang Tan, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2232133-e2232133
Open Access | Times Cited: 64
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175300-175300
Closed Access | Times Cited: 34
Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
Brain Research (2023) Vol. 1815, pp. 148462-148462
Closed Access | Times Cited: 19
The avBNSTGABA–VTA and avBNSTGABA–DRN pathways are respectively involved in the regulation of anxiety-like behaviors in parkinsonian rats
Ruotong Li, Guoyi Tang, Jie Yang, et al.
Neurochemistry International (2024) Vol. 175, pp. 105720-105720
Closed Access | Times Cited: 6
Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson’s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk
Shubhendu M. Shirgadwar, Rahul Kumar, Preeti Kumari, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S109-S124
Open Access | Times Cited: 26
Parkinson’s Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022)
Tong Zhang, Rui Yang, Juhua Pan, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1477-1489
Open Access | Times Cited: 16
Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson’s disease related anxiety disorder
Mei-Xue Dong, Ling Hu, Youdong Wei, et al.
Neuroscience Letters (2021) Vol. 745, pp. 135626-135626
Closed Access | Times Cited: 32
Art therapy as a comprehensive complementary treatment for Parkinson’s disease
Tom Ettinger, Marygrace Berberian, Ikuko Acosta, et al.
Frontiers in Human Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Parkinson’s disease with anxiety: clinical characteristics and their correlation with oxidative stress, inflammation, and pathological proteins
Teng-hong Lian, Weijiao Zhang, Danning Li, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Levodopa-synergistic CBT intervention improves Parkinson’s disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway
Niu Ji, Shanshan Lu, Bingchao Xu, et al.
Neurological Sciences (2025)
Open Access
Agarwood as a neuroprotective agent: a comprehensive review of existing evidence and potential avenues for future research
Ankur Das, Khaleda Begum, Raja Ahmed, et al.
Phytochemistry Reviews (2025)
Closed Access
Prevalence of experienced changes in artistic and everyday creativity in people with Parkinson’s disease
Blanca T. M. Spee, Julia Crone, Sirwan K.L. Darweesh, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms
Detao Meng, Zhaohui Jin, Yixuan Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2259-2266
Open Access | Times Cited: 9
A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
Lucia Batzu, Aleksandra Podlewska, Lucy L. Gibson, et al.
International review of neurobiology (2024), pp. 59-97
Closed Access | Times Cited: 3
Development and evaluation of anxiolytic potential of bagels incorporated with banana peel flour and lavender
Sana Manzoor, Allah Rakha, Hina Rasheed, et al.
Journal of Agriculture and Food Research (2024) Vol. 15, pp. 101029-101029
Open Access | Times Cited: 2
Aqueous extract of Swietenia macrophylla leaf exerts an anti-inflammatory effect in a murine model of Parkinson’s disease induced by 6-OHDA
Váldina Solimar Lopes Cardoso, Anderson Valente-Amaral, Rayan Fidel Martins Monteiro, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Amygdalo‐nigral circuit mediates stress‐induced vulnerability to the parkinsonian toxin MPTP
Hongwei Cai, Pei Zhang, Tongxia Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1940-1952
Open Access | Times Cited: 6
The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study
Nobutaka Hattori, Yuki Kogo, Michinori Koebis, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 9
The effect of physical exercise on anxiety in people with parkinson’s disease: A systematic review of randomized control trials
Romaisa Abuoaf, Rooh AlKaabi, Aisha Mohamed Saleh, et al.
Neurorehabilitation (2023) Vol. 52, Iss. 3, pp. 387-402
Closed Access | Times Cited: 5
Effect of Rhythmically Cued Exercise Interventions on Functions in Patients With Parkinson Disease: A Meta-Analysis
Xin Huang, Ke Dong, Chu Gan, et al.
Physical Therapy (2023) Vol. 104, Iss. 3
Open Access | Times Cited: 5
Serotonin and dopamine depletion in distinct brain regions may cause anxiety in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice as a model of early Parkinson’s disease
Ruixi Yang, Suzhen Ye, Shuping Zhang, et al.
Neuroreport (2023) Vol. 34, Iss. 11, pp. 551-559
Open Access | Times Cited: 4
The α1 and γ2 subunit-containing GABAA receptor-mediated inhibitory transmission in the anteroventral bed nucleus of stria terminalis is involved in the regulation of anxiety in rats with substantia nigra lesions
Ruotong Li, Yong Wang, Yaxin Yang, et al.
Neuropharmacology (2023) Vol. 237, pp. 109645-109645
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top